Patents by Inventor Bindhumadhavan GURURAJAN

Bindhumadhavan GURURAJAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ribociclib Tablet
    Publication number: 20200390771
    Abstract: The present disclosure is directed to oral tablet of ribociclib including its salt(s). One embodiment of the present disclosure is directed to tablet of ribociclib with high drug load with an immediate release profile. One embodiment of the present disclosure is directed to coated tablet of ribociclib. Another embodiment of the present disclosure is directed to coated tablet of ribociclib where the coating is an advanced moisture barrier coating (e.g., Opadry® amb II coating where the coating is PVA based).
    Type: Application
    Filed: August 26, 2020
    Publication date: December 17, 2020
    Inventors: Rui Costa, Arnaud Grandeury, Bindhumadhavan Gururajan
  • Ribociclib tablet
    Patent number: 10799506
    Abstract: The present disclosure is directed to oral tablet of ribociclib including its salt(s). One embodiment of the present disclosure is directed to tablet of ribociclib with high drug load with an immediate release profile. One embodiment of the present disclosure is directed to coated tablet of ribociclib. Another embodiment of the present disclosure is directed to coated tablet of ribociclib where the coating is an advanced moisture barrier coating (e.g., Opadry® amb II coating where the coating is PVA based).
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: October 13, 2020
    Assignee: NOVARTIS AG
    Inventors: Bindhumadhavan Gururajan, Arnaud Grandeury, Rui Costa
  • RIBOCICLIB TABLET
    Publication number: 20180071292
    Abstract: The present disclosure is directed to oral tablet of ribociclib including its salt(s). One embodiment of the present disclosure is directed to tablet of ribociclib with high drug load with an immediate release profile. One embodiment of the present disclosure is directed to coated tablet of ribociclib. Another embodiment of the present disclosure is directed to coated tablet of ribociclib where the coating is an advanced moisture barrier coating (e.g., Opadry® amb II coating where the coating is PVA based).
    Type: Application
    Filed: April 14, 2016
    Publication date: March 15, 2018
    Inventors: Bindhumadhavan Gururajan, Arnaud Grandeury, Rui Costa
  • (trimethoxyphenylamino) pyrimidinyl formulations
    Patent number: 8951504
    Abstract: There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: February 10, 2015
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Bindhumadhavan Gururajan, Farhan Abdul Karim Alhusban, Ian Paul Gabbott, Dawn Sievwright, David Bradley Brook
  • (Trimethoxyphenylamino) Pyrimidinyl Formulations
    Publication number: 20140271493
    Abstract: There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.
    Type: Application
    Filed: May 29, 2014
    Publication date: September 18, 2014
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Bindhumadhavan Gururajan, Farhan Abdul Karim Alhusban, Ian Paul Gabbott, Dawn Sievwright, David Bradley Brook Simpson
  • (Trimethoxyphenylamino) pyrimidinyl formulations
    Patent number: 8771648
    Abstract: There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: July 8, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Bindhumadhavan Gururajan, Farhan Abdul Karim Alhusban, Ian Paul Gabbott, David Bradley Brook Simpson, Dawn Sievwright
  • (TRIMETHOXYPHENYLAMINO) PYRIMIDINYL FORMULATIONS
    Publication number: 20130058876
    Abstract: There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.
    Type: Application
    Filed: July 27, 2012
    Publication date: March 7, 2013
    Inventors: Bindhumadhavan GURURAJAN, Farhan Abdul Karim ALHUSBAN, Ian Paul GABBOTT, David Bradley Brook SIMPSON, Dawn SIEVWRIGHT